Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd has allotted 4,11,000 equity shares under the ESOP Scheme 2020 and ESOP Scheme 2024, increasing the paid-up equity share capital to ₹18,49,64,47,030.

Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd has received a credit rating of [ICRA]AAA (Stable) from ICRA Limited for its issuer rating, and [ICRA]AA+(Stable) for its subordinated debt rating. The ratings are specific to the terms and conditions of the instruments as indicated to ICRA by the company.

Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd has received an order from IRDAI for not complying with EoM limits for FY 2024-25, and has been warned and directed not to open new places of business for six months.

Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd held its 18th Annual General Meeting (AGM) on August 12, 2026, through video conferencing. The meeting was attended by the Chairperson, Managing Director, and several directors, as well as representatives of the Joint Statutory Auditors and Secretarial Auditor. The Company Secretary reported that the AGM was conducted in accordance with applicable laws and regulations, and the Annual certificate on implementation of the Employee stock option scheme was available for inspection.

Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd has received approval from IRDAI for the appointment of Mr. Ashwani Bhatia as the Chairperson of the company, effective June 3, 2026.

Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd has announced its Q1 FY27 earnings conference call transcript, highlighting industry initiatives, awareness campaigns, and financial performance. The company has transitioned to Ind AS accounting standard and reported a growth of 31.6% in retail health insurance. The management has also discussed ongoing initiatives such as standardization of care pathways, position statements, and common empanelment with over 3,000 hospitals.

Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd has submitted a newspaper publication of its unaudited financial results for the quarter ended June 30, 2026, as required by Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd has informed the Exchange about the link of recording of the earnings conference call held on July 30, 2026, for the quarter ended June 30, 2026.

Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd reported a 93% PAT growth to ₹138 crore for the quarter ended June 30, 2026, with a 32% increase in Gross Written Premium (GWP) to ₹2,150 crore, and a 47% growth in retail health business, contributing to an increase in Retail Health Market Share to 11.1%.

Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd has announced its Q1FY2027 results, with a 31.7% y-o-y growth in Gross Written Premium (GWP) to ₹ 2,150 crore and a near doubling of Profit After Tax (PAT) to ₹ 137.8 crore. The company has also transitioned to Indian Accounting Standards (Ind AS) from Q1FY2027, which is expected to enhance financial transparency and align reporting practices with global benchmarks.

Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd has announced the outcome of its Board meeting, where it has approved the issuance of non-convertible debentures of up to ₹500 crores on a private placement basis. The company has also released unaudited financial results for the quarter ended June 30, 2026, along with a limited review report from its auditors.

Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd has announced unaudited financial results for the quarter ended June 2026 and plans to raise funds by issuing debentures up to ₹500 crores.

Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd has announced a conference call to discuss Q1FY27 results on July 30, 2026.

Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd will hold a board meeting on July 30, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, and to consider a proposal for fund raising by way of issuance of Non-Convertible Debentures.

Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd has allotted 1,476,432 equity shares of face value ₹10 each on June 23, 2026. This allotment was made under the Niva Bupa Employee Stock Option Plan 2020 (2,42,855 shares) and ESOP Scheme 2024 (12,33,577 shares), upon exercise of options by eligible grantees. Consequently, the company's paid-up equity share capital increased to ₹18,49,23,37,030, comprising 1,84,92,33,703 equity shares, which will rank pari-passu with existing shares.

Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd announced that Care Ratings Limited has reaffirmed its 'CARE AA Stable' credit rating for the company's ₹250.00 crore Non-Convertible Debentures. This reaffirmation, received on June 22, 2026, indicates a continued strong and stable credit profile for the company's debt instruments, providing assurance regarding its financial health and ability to meet debt obligations.